Research Article

LC and UV Methods for Lamotrigine Determination in Pharmaceutical Formulation

Figure 2

Mobile phase without the additive triethylamine (0.3%) (a) and the use and influence in peak shapes with the additive triethylamine (0.3%) in the mobile phase (b).
860168.fig.002a
(a)
860168.fig.002b
(b)